share_log

The Recent 9.7% Gain Must Have Brightened CEO Wei He's Week, Liaoning He Eye Hospital Group Co., LTD.'s (SZSE:301103) Most Bullish Insider

最近の9.7%の成長は、CEOWei Heの週を明るくしたに違いない。Liaoning He Eye Hospital Group Co.、Ltd。 (SZSE:301103)最も強気なインサイダー

Simply Wall St ·  05/08 18:45

Key Insights

  • Insiders appear to have a vested interest in Liaoning He Eye Hospital Group's growth, as seen by their sizeable ownership
  • 51% of the business is held by the top 5 shareholders
  • Institutional ownership in Liaoning He Eye Hospital Group is 12%

To get a sense of who is truly in control of Liaoning He Eye Hospital Group Co., LTD. (SZSE:301103), it is important to understand the ownership structure of the business. With 38% stake, individual insiders possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

As a result, insiders scored the highest last week as the company hit CN¥4.3b market cap following a 9.7% gain in the stock.

Let's delve deeper into each type of owner of Liaoning He Eye Hospital Group, beginning with the chart below.

ownership-breakdown
SZSE:301103 Ownership Breakdown May 8th 2024

What Does The Institutional Ownership Tell Us About Liaoning He Eye Hospital Group?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

We can see that Liaoning He Eye Hospital Group does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Liaoning He Eye Hospital Group, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
SZSE:301103 Earnings and Revenue Growth May 8th 2024

Hedge funds don't have many shares in Liaoning He Eye Hospital Group. The company's CEO Wei He is the largest shareholder with 19% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 12% and 7.7%, of the shares outstanding, respectively.

To make our study more interesting, we found that the top 5 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.

Insider Ownership Of Liaoning He Eye Hospital Group

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

It seems insiders own a significant proportion of Liaoning He Eye Hospital Group Co., LTD.. It has a market capitalization of just CN¥4.3b, and insiders have CN¥1.7b worth of shares in their own names. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.

General Public Ownership

With a 20% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Liaoning He Eye Hospital Group. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Private Equity Ownership

Private equity firms hold a 12% stake in Liaoning He Eye Hospital Group. This suggests they can be influential in key policy decisions. Sometimes we see private equity stick around for the long term, but generally speaking they have a shorter investment horizon and -- as the name suggests -- don't invest in public companies much. After some time they may look to sell and redeploy capital elsewhere.

Private Company Ownership

Our data indicates that Private Companies hold 12%, of the company's shares. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

Public Company Ownership

Public companies currently own 5.0% of Liaoning He Eye Hospital Group stock. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged. This holding is probably worth investigating further.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. For example, we've discovered 3 warning signs for Liaoning He Eye Hospital Group (2 are potentially serious!) that you should be aware of before investing here.

Of course this may not be the best stock to buy. So take a peek at this free free list of interesting companies.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする